The effectiveness of immunotherapy is primarily influenced by the tumor immune microenvironment (TIME) phenotype, particularly CD8 T cells infiltration into tumors, which positively correlates with immunotherapy efficacy and survival (3–6). Here, CD8A is linked to neoplasm.